ldn
Low-Dose Naltrexone (LDN) in Solid Organ Transplant Recipients on Chronic Immunosuppression
CLINICAL REFERENCE NOTE Low-Dose Naltrexone (LDN) in Solid Organ Transplant Recipients on Chronic Immunosuppression Prepared by Yoon Hang Kim, MD, MPH | Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Reviewed: May 2026 | Internal clinical reference — not patient-facing Bottom line The concern is pharmacodynamic and entirely theoretical.